Clinical trial
Termination of Early Pregnancy in Scarred Uterus With Letrozole and Misoprostol Compared to Misoprostol Alone
NCT05067309 is registered in ClinicalTrials.gov with Ahmed Elsayed Aref as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Termination of Early Pregnancy in Scarred Uterus With Letrozole and Misoprostol Compared to Misoprostol Alone
- Lead sponsor
- Ahmed Elsayed Aref
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- August 1, 2022
- Enrollment
- 1 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
termination of early pregnancy in scarred uterus